Stay updated on Miransertib in Overgrowth Spectrum Clinical Trial
Sign up to get notified when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.

Latest updates to the Miransertib in Overgrowth Spectrum Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.6.5 was added and v3.6.4 was removed, indicating a minor update to the page’s underlying version. It appears to be a background system/format change rather than content changes to the MOSAIC study page.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a new iteration of the page content. It represents a minor update to the page rendering and does not change the information shown.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a small maintenance update to the page's versioning information.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, signaling a newer template/version update without changing the study data.SummaryDifference0.0%

- Check67 days agoChange DetectedThe MOSAIC study page now indicates that recruitment is closed. It also adds user-guidance sections to help readers understand the study record and how to join.SummaryDifference0.5%

- Check74 days agoChange DetectedThe revision label on the page was updated from v3.5.4 to v3.5.5, indicating a minor maintenance update to the page. No study data, eligibility criteria, or results were altered.SummaryDifference0.0%

Stay in the know with updates to Miransertib in Overgrowth Spectrum Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.